Firefly Neuroscience (AIFF) Cash & Current Investments (2010 - 2026)

Firefly Neuroscience has reported Cash & Current Investments for 17 years, with the latest figure at $9.2 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments rose 55.9% year-over-year to $9.2 million in Q2 2026; TTM through Jun 2026 was $9.2 million, a 55.9% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 51.77% from the prior year.
• Cash & Current Investments was $9.2 million for Q2 2026 at Firefly Neuroscience, up from $3.1 million in the prior quarter.
• The five-year high for Cash & Current Investments was $9.5 million in Q1 2025, with the low at $58000.0 in Q4 2022.
• Average Cash & Current Investments over 5 years is $2.7 million, with a median of $1.7 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments slumped 98.82% in 2022, then surged 3594.83% in 2023.
• Over 5 years, Cash & Current Investments stood at $58000.0 in 2022, then soared by 3594.83% to $2.1 million in 2023, then retreated by 15.54% to $1.8 million in 2024, then jumped by 51.77% to $2.7 million in 2025, then jumped by 235.86% to $9.2 million in 2026.
• The last three Cash & Current Investments figures came in at $9.2 million (Q2 2026), $3.1 million (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.